Literature DB >> 31385810

Long noncoding RNAs in thyroid cancer.

Mahsa Sedaghati1, Electron Kebebew.   

Abstract

PURPOSE OF REVIEW: Our understanding of the molecular pathology events involved in thyroid cancer initiation and progression and its subtypes has markedly improved as a result of multiomic studies. Recently, long noncoding RNA (lncRNA) have been shown to have a role in cancer initiation and progression and have also been studied in thyroid cancer. RECENT
FINDINGS: lncRNA are dysregulated in thyroid cancer. lncRNA have tumor suppressive and oncogenic function in thyroid cancer cells and play a role in some of the established genetic drivers of thyroid cancer initiation and progression. Lastly, some lncRNA are associated with clinicopathologic features of thyroid cancer and circulating blood lncRNA could potentially detect the presence of thyroid cancer.
SUMMARY: We highlight the possible clinical utility of analyzing lncRNAs as biomarkers for thyroid cancer diagnosis and prognosis and their association with common genetic changes associated with thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31385810     DOI: 10.1097/MED.0000000000000497

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  14 in total

1.  Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis.

Authors:  Sina Dadafarin; Michelle Carnazza; Humayun K Islam; Augustine Moscatello; Raj K Tiwari; Jan Geliebter
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The Blood Biomarkers of Thyroid Cancer.

Authors:  Weiran Wang; Jingtao Chang; Baosong Jia; Jing Liu
Journal:  Cancer Manag Res       Date:  2020-07-06       Impact factor: 3.989

3.  Long non-coding RNA DIO3OS/let-7d/NF-κB2 axis regulates cells proliferation and metastasis of thyroid cancer cells.

Authors:  Mingming Wang; Jin Li; Zhongkun Zuo; Chutong Ren; Tenglong Tang; Chen Long; Yi Gong; Fei Ye; Zhihong Wang; Jiangsheng Huang
Journal:  J Cell Commun Signal       Date:  2020-10-15       Impact factor: 5.782

4.  Long noncoding RNA FER1L4 promotes the malignant processes of papillary thyroid cancer by targeting the miR-612/ Cadherin 4 axis.

Authors:  Luyao Wu; Yu Ding; Houchao Tong; Xi Zhuang; Jingsheng Cai; Yan Si; Hao Zhang; Xiaoting Wang; Meiping Shen
Journal:  Cancer Cell Int       Date:  2021-07-21       Impact factor: 5.722

5.  RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer.

Authors:  Berta Luzón-Toro; Leticia Villalba-Benito; Raquel María Fernández; Ana Torroglosa; Guillermo Antiñolo; Salud Borrego
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

6.  TNRC6C-AS1 Promotes Thyroid Cancer Progression by Upregulating LPAR5 via miR-513c-5p.

Authors:  Chuanming Tong; Chuan Wang; Yajie Wang; Xiongsheng Xiao
Journal:  Cancer Manag Res       Date:  2021-08-06       Impact factor: 3.989

Review 7.  Emerging Biomarkers in Thyroid Practice and Research.

Authors:  Shipra Agarwal; Andrey Bychkov; Chan-Kwon Jung
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 8.  Papillary Thyroid Cancer Prognosis: An Evolving Field.

Authors:  Salvatore Ulisse; Enke Baldini; Augusto Lauro; Daniele Pironi; Domenico Tripodi; Eleonora Lori; Iulia Catalina Ferent; Maria Ida Amabile; Antonio Catania; Filippo Maria Di Matteo; Flavio Forte; Alberto Santoro; Piergaspare Palumbo; Vito D'Andrea; Salvatore Sorrenti
Journal:  Cancers (Basel)       Date:  2021-11-07       Impact factor: 6.639

9.  Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression.

Authors:  Rui Li; Taihu Wan; Jie Qu; Yang Yu; Ruipeng Zheng
Journal:  Aging (Albany NY)       Date:  2020-09-10       Impact factor: 5.682

10.  The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.

Authors:  Yong Huang; KeWei Zhang; Yinghua Li; Yuyin Dai; Hongguang Zhao
Journal:  Aging (Albany NY)       Date:  2020-11-16       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.